Capital Investment Advisors, LLC Eli Lilly & CO Transaction History

Capital Investment Advisors, LLC

$4.25 Billion
Q1 2024

A detailed history of Capital Investment Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Capital Investment Advisors, LLC holds 26,054 shares of LLY stock, worth $23.8 Million. This represents 0.48% of its overall portfolio holdings.

Number of Shares

26,054

Previous 26,274 0.84%

Holding current value

$23.8 Million

Previous $15.3 Million 32.34%

% of portfolio

0.48%

Previous 0.39%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 15, 2024	SELL	$592.2 - $792.28 $130,284 - $174,301	-220 Reduced 0.84%	26,054 $20.3 Million
Q4 2023 Jan 05, 2024	BUY	$525.19 - $619.13 $14,180 - $16,716	27 Added 0.1%	26,274 $15.3 Million
Q3 2023 Oct 16, 2023	BUY	$434.7 - $599.3 $11.4 Million - $15.7 Million	26,247 New	26,247 $14.1 Million
Q1 2023 Apr 10, 2023	SELL	$310.63 - $364.82 $317,153 - $372,481	-1,021 Reduced 3.57%	27,547 $9.46 Million
Q4 2022 Jan 05, 2023	SELL	$321.55 - $374.67 $286,822 - $334,205	-892 Reduced 3.03%	28,568 $10.5 Million

Q3 2022 Oct 05, 2022	SELL	$296.48 - $337.87 $104,360 - $118,930	-352 Reduced 1.18%	29,460 $9.53 Million
Q2 2022 Jul 06, 2022	SELL	$278.73 - $327.27 $57,975 - $68,072	-208 Reduced 0.69%	29,812 $9.67 Million
Q1 2022 Apr 13, 2022	BUY	$234.69 - $291.66 $53,978 - $67,081	230 Added 0.77%	30,020 $8.6 Million
Q4 2021 Jan 10, 2022	BUY	$224.85 - $279.04 $29,455 - $36,554	131 Added 0.44%	29,790 $8.23 Million
Q3 2021 Oct 13, 2021	SELL	$221.6 - $272.71 $98,612 - $121,355	-445 Reduced 1.48%	29,659 $6.85 Million
Q2 2021 Jul 14, 2021	BUY	$180.55 - $233.54 $177,480 - $229,569	983 Added 3.38%	30,104 $6.91 Million
Q1 2021 Apr 27, 2021	SELL	$164.32 - $212.72 $139,014 - $179,961	-846 Reduced 2.82%	29,121 $5.44 Million
Q4 2020 Jan 21, 2021	SELL	$130.46 - $172.63 $71,883 - $95,119	-551 Reduced 1.81%	29,967 $5.06 Million
Q3 2020 Oct 29, 2020	SELL	$146.22 - $169.13 $7,895 - $9,133	-54 Reduced 0.18%	30,518 $4.52 Million
Q2 2020 Jul 20, 2020	SELL	$136.42 - $164.18 $43,381 - $52,209	-318 Reduced 1.03%	30,572 $5.02 Million
Q1 2020 Apr 13, 2020	SELL	$119.05 - $147.35 $117,383 - $145,287	-986 Reduced 3.09%	30,890 $4.29 Million
Q4 2019 Jan 21, 2020	SELL	$106.92 - $132.43 $8,767 - $10,859	-82 Reduced 0.26%	31,876 $4.19 Million
Q3 2019 Oct 24, 2019	SELL	$106.79 - $116.16 $14,096 - $15,333	-132 Reduced 0.41%	31,958 $3.57 Million
Q2 2019 Jul 17, 2019	SELL	$110.79 - $129.32 $93,174 - $108,758	-841 Reduced 2.55%	32,090 $3.56 Million
Q1 2019 Apr 11, 2019	SELL	$111.31 - $131.02 $100,290 - $118,049	-901 Reduced 2.66%	32,931 $4.27 Million
Q4 2018 Jan 17, 2019	SELL	$105.9 - $118.64 $182,571 - $204,535	-1,724 Reduced 4.85%	33,832 $3.92 Million
Q3 2018 Oct 15, 2018	BUY	$85.86 - $107.31 $173,265 - $216,551	2,018 Added 6.02%	35,556 $3.82 Million
Q2 2018 Jul 10, 2018	SELL	$75.7 - $86.88 $120,287 - $138,052	-1,589 Reduced 4.52%	33,538 $2.86 Million
Q1 2018 Apr 16, 2018	BUY	$74.21 - $87.6 $77,772 - $91,804	1,048 Added 3.08%	35,127 $2.72 Million
Q4 2017 Jan 17, 2018	SELL	$81.94 - $87.89 $27,695 - $29,706	-338 Reduced 0.98%	34,079 $2.88 Million
Q3 2017 Oct 17, 2017	BUY	$77.07 - $85.54 $2.65 Million - $2.94 Million	34,417	34,417 $2.94 Million

Others Institutions Holding LLY

# of Institutions

3,725

Shares Held

738M

Call Options Held

7.09M

Put Options Held

7.24M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $869B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Investment Advisors, LLC with notifications on news.

Account

Capital Investment Advisors, LLC Eli Lilly & CO Transaction History